Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
IDF continues counterterrorism operations in Gaza Strip, including destroying terror tunnels - 2Journalist reported killed in the Gaza Strip
- 3Congolese rape survivors search in vain for medicine after USAID cuts
- 41,000-mile Saharan dust storm, from the sky and from the ground
- 5CVS forecasts 2026 profit above estimates on strong performance
- Israeli Chief of Staff declares new border with Gaza Strip
- Internet goes (cocoa) nuts: The funniest reactions to 12 tonne theft of KitKat bars
- Russia patents space station designed to generate artificial gravity
- Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- Seven deaths possibly linked to malfunctioning glucose monitors
- Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
- Does physics say that free will doesn't exist?
- Holiday travel: Best days to hit the road as 110 million Americans expected to drive over Christmas and New Year's
- Internet Bookkeeping Programming for Consultants
